Invention Grant
- Patent Title: Aminopyridine derived compounds as LRRK2 inhibitors
-
Application No.: US14758884Application Date: 2013-12-30
-
Publication No.: US09321748B2Publication Date: 2016-04-26
- Inventor: Gitte Kobberøe Mikkelsen , Laurent David , Stephen Watson , Garrick Paul Smith , Douglas Stewart Williamson , I-Jen Chen
- Applicant: H. Lundbeck A/S , Vernalis (R&D) Ltd.
- Applicant Address: DK Valby GB Winnersh
- Assignee: H. Lundbeck A/S,Vernalis (R&D) Ltd.
- Current Assignee: H. Lundbeck A/S,Vernalis (R&D) Ltd.
- Current Assignee Address: DK Valby GB Winnersh
- Agent Mary Catherine Di Nunzio; Jeffrey I. Auerbach
- Priority: DK201300004 20130102; DK201300136 20130311
- International Application: PCT/EP2013/078105 WO 20131230
- International Announcement: WO2014/106612 WO 20140710
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; C07D403/14 ; C07D413/04 ; C07D413/14
Abstract:
The present invention is directed to aminopyridine derived compounds of formula (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such a Lewy body dementia, Parkinson's disease or cancer.
Public/Granted literature
- US20150336942A1 Aminopyridine derived compounds as LRRK2 inhibitors Public/Granted day:2015-11-26
Information query
